Very efficient platform purification process for gene therapy medicines using innovative chromatography technology

Lead Participant: BIOTOOLOMICS LIMITED

Abstract

Gene therapy has formed one of the most advanced medical technology in the modern precision medicine area. It has shown some unique advantages in curing certain diseases. There is a growing demand of high quality viral medicines to be manufactured with efficient and cost-effective processes. This feasibility study project proposes a much efficient purification process to address the technical challenges facing this emerging market.

Lead Participant

Project Cost

Grant Offer

BIOTOOLOMICS LIMITED £95,826 £ 67,078
 

Participant

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST

Publications

10 25 50